Skip to main content
Top
Published in: Arthritis Research & Therapy 2/2011

Open Access 01-04-2011 | Research article

Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development

Authors: Alexandra Bäcklund, Meirav Holmdahl, Ragnar Mattsson, Katarina Håkansson, Veronica Lindström, Kutty Selva Nandakumar, Anders Grubb, Rikard Holmdahl

Published in: Arthritis Research & Therapy | Issue 2/2011

Login to get access

Abstract

Introduction

Collagen-induced arthritis (CIA) is a mouse model for rheumatoid arthritis (RA) and is induced after immunization with type II collagen (CII). CIA, like RA, is an autoimmune disease leading to destruction of cartilage and joints, and both the priming and inflammatory phases have been suggested to be dependent on proteases. In particular, the cysteine proteases have been proposed to be detrimental to the arthritic process and even immunomodulatory. A natural inhibitor of cysteine proteases is cystatin C.

Methods

Cystatin C-deficient, sufficient and heterozygous mice were tested for onset, incidence and severity of CIA. The effect of cystatin C-deficiency was further dissected by testing the inflammatory effector phase of CIA; that is, collagen antibody-induced arthritis model and priming phase, that is, T cell response both in vivo and in vitro. In addition, in order to determine the importance of T cells and antigen-presenting cells (APCs), these cell populations were separated and in vitro T cell responses determined in a mixed co-culture system. Finally, flow cytometry was used in order to further characterize cell populations in cystatin C-deficient mice.

Results

Here, we show that mice lacking cystatin C, develop arthritis at a higher incidence and an earlier onset than wild-type controls. Interestingly, when the inflammatory phase of CIA was examined independently from immune priming then cystatin C-deficiency did not enhance the arthritis profile. However, in line with the enhanced CIA, there was an increased T cell and B cell response as delayed-type hypersensitivity reaction and anti-CII antibody titers were elevated in the cystatin C-deficient mice after immunization. In addition, the ex vivo naïve APCs from cystatin C-deficient mice had a greater capacity to stimulate T cells. Interestingly, dendritic cells had a more activated phenotype in naïve cystatin C-deficient mice.

Conclusions

The lack of cystatin C enhances CIA and primarily affects in vivo priming of the immune system. Although the mechanism of this is still unknown, we show evidence for a more activated APC compartment, which would elevate the autoimmune response towards CII, thus resulting in an enhanced development of chronic arthritis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gabrijelcic D, Annan-Prah A, Rodic B, Rozman B, Cotic V, Turk V: Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. J Clin Chem Clin Biochem. 1990, 28: 149-153.PubMed Gabrijelcic D, Annan-Prah A, Rodic B, Rozman B, Cotic V, Turk V: Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. J Clin Chem Clin Biochem. 1990, 28: 149-153.PubMed
2.
go back to reference Lenarcic B, Gabrijelcic D, Rozman B, Drobnic-Kosorok M, Turk V: Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe Seyler. 1988, 369 (Suppl): 257-261.PubMed Lenarcic B, Gabrijelcic D, Rozman B, Drobnic-Kosorok M, Turk V: Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe Seyler. 1988, 369 (Suppl): 257-261.PubMed
3.
go back to reference Trabandt A, Gay RE, Fassbender HG, Gay S: Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum. 1991, 34: 1444-1451. 10.1002/art.1780341116.CrossRef Trabandt A, Gay RE, Fassbender HG, Gay S: Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum. 1991, 34: 1444-1451. 10.1002/art.1780341116.CrossRef
4.
go back to reference Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Nilson-Hamilton M, Hamilton RT, McGhee JR, Fassbender HG, Gay S: Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. Matrix. 1990, 10: 349-361.CrossRef Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Nilson-Hamilton M, Hamilton RT, McGhee JR, Fassbender HG, Gay S: Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. Matrix. 1990, 10: 349-361.CrossRef
5.
go back to reference Reddy VY, Zhang QY, Weiss SJ: Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA. 1995, 92: 3849-3853. 10.1073/pnas.92.9.3849.CrossRef Reddy VY, Zhang QY, Weiss SJ: Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA. 1995, 92: 3849-3853. 10.1073/pnas.92.9.3849.CrossRef
6.
go back to reference Yasuda Y, Kaleta J, Bromme D: The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev. 2005, 57: 973-993. 10.1016/j.addr.2004.12.013.CrossRef Yasuda Y, Kaleta J, Bromme D: The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev. 2005, 57: 973-993. 10.1016/j.addr.2004.12.013.CrossRef
7.
go back to reference Abrahamson M, Barrett AJ, Salvesen G, Grubb A: Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem. 1986, 261: 11282-11289.PubMed Abrahamson M, Barrett AJ, Salvesen G, Grubb A: Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem. 1986, 261: 11282-11289.PubMed
8.
go back to reference Grubb AO: Cystatin C--properties and use as diagnostic marker. Adv Clin Chem. 2000, 35: 63-99. full_text.CrossRef Grubb AO: Cystatin C--properties and use as diagnostic marker. Adv Clin Chem. 2000, 35: 63-99. full_text.CrossRef
9.
go back to reference Taupin P, Ray J, Fischer WH, Suhr ST, Hakansson K, Grubb A, Gage FH: FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron. 2000, 28: 385-397. 10.1016/S0896-6273(00)00119-7.CrossRef Taupin P, Ray J, Fischer WH, Suhr ST, Hakansson K, Grubb A, Gage FH: FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron. 2000, 28: 385-397. 10.1016/S0896-6273(00)00119-7.CrossRef
10.
go back to reference Brage M, Lie A, Ransjo M, Kasprzykowski F, Kasprzykowska R, Abrahamson M, Grubb A, Lerner UH: Osteoclastogenesis is decreased by cysteine proteinase inhibitors. Bone. 2004, 34: 412-424. 10.1016/j.bone.2003.11.018.CrossRef Brage M, Lie A, Ransjo M, Kasprzykowski F, Kasprzykowska R, Abrahamson M, Grubb A, Lerner UH: Osteoclastogenesis is decreased by cysteine proteinase inhibitors. Bone. 2004, 34: 412-424. 10.1016/j.bone.2003.11.018.CrossRef
11.
go back to reference Olsson T, Nygren J, Hakansson K, Lundblad C, Grubb A, Smith ML, Wieloch T: Gene deletion of cystatin C aggravates brain damage following focal ischemia but mitigates the neuronal injury after global ischemia in the mouse. Neuroscience. 2004, 128: 65-71. 10.1016/j.neuroscience.2004.06.024.CrossRef Olsson T, Nygren J, Hakansson K, Lundblad C, Grubb A, Smith ML, Wieloch T: Gene deletion of cystatin C aggravates brain damage following focal ischemia but mitigates the neuronal injury after global ischemia in the mouse. Neuroscience. 2004, 128: 65-71. 10.1016/j.neuroscience.2004.06.024.CrossRef
12.
go back to reference Bengtsson E, To F, Grubb A, Hakansson K, Wittgren L, Nilsson J, Jovinge S: Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice. Atherosclerosis. 2005, 180: 45-53. 10.1016/j.atherosclerosis.2004.12.025.CrossRef Bengtsson E, To F, Grubb A, Hakansson K, Wittgren L, Nilsson J, Jovinge S: Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice. Atherosclerosis. 2005, 180: 45-53. 10.1016/j.atherosclerosis.2004.12.025.CrossRef
13.
go back to reference Bengtsson E, To F, Hakansson K, Grubb A, Branen L, Nilsson J, Jovinge S: Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2005, 25: 2151-2156. 10.1161/01.ATV.0000179600.34086.7d.CrossRef Bengtsson E, To F, Hakansson K, Grubb A, Branen L, Nilsson J, Jovinge S: Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2005, 25: 2151-2156. 10.1161/01.ATV.0000179600.34086.7d.CrossRef
14.
go back to reference Bokarewa M, Abrahamson M, Levshin N, Egesten A, Grubb A, Dahlberg L, Tarkowski A: Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol. 2007, 34: 1293-1301.PubMed Bokarewa M, Abrahamson M, Levshin N, Egesten A, Grubb A, Dahlberg L, Tarkowski A: Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol. 2007, 34: 1293-1301.PubMed
15.
go back to reference Leung-Tack J, Tavera C, Gensac MC, Martinez J, Colle A: Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg. Exp Cell Res. 1990, 188: 16-22. 10.1016/0014-4827(90)90272-C.CrossRef Leung-Tack J, Tavera C, Gensac MC, Martinez J, Colle A: Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg. Exp Cell Res. 1990, 188: 16-22. 10.1016/0014-4827(90)90272-C.CrossRef
16.
go back to reference Leung-Tack J, Tavera C, Martinez J, Colle A: Neutrophil chemotactic activity is modulated by human cystatin C, an inhibitor of cysteine proteases. Inflammation. 1990, 14: 247-258. 10.1007/BF00915809.CrossRef Leung-Tack J, Tavera C, Martinez J, Colle A: Neutrophil chemotactic activity is modulated by human cystatin C, an inhibitor of cysteine proteases. Inflammation. 1990, 14: 247-258. 10.1007/BF00915809.CrossRef
17.
go back to reference Sun Q: Growth stimulation of 3T3 fibroblasts by cystatin. Exp Cell Res. 1989, 180: 150-160. 10.1016/0014-4827(89)90219-X.CrossRef Sun Q: Growth stimulation of 3T3 fibroblasts by cystatin. Exp Cell Res. 1989, 180: 150-160. 10.1016/0014-4827(89)90219-X.CrossRef
18.
go back to reference Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA: Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev. 1990, 118: 193-232. 10.1111/j.1600-065X.1990.tb00817.x.CrossRef Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA: Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev. 1990, 118: 193-232. 10.1111/j.1600-065X.1990.tb00817.x.CrossRef
19.
go back to reference Holmdahl R, Vingsbo C, Mo JA, Michaelsson E, Malmstrom V, Jansson L, Brunsberg U: Chronicity of tissue-specific experimental autoimmune disease: a role for B cells?. Immunol Rev. 1995, 144: 109-135. 10.1111/j.1600-065X.1995.tb00067.x.CrossRef Holmdahl R, Vingsbo C, Mo JA, Michaelsson E, Malmstrom V, Jansson L, Brunsberg U: Chronicity of tissue-specific experimental autoimmune disease: a role for B cells?. Immunol Rev. 1995, 144: 109-135. 10.1111/j.1600-065X.1995.tb00067.x.CrossRef
20.
go back to reference Stuart JM, Tomoda K, Yoo TJ, Townes AS, Kang AH: Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum. 1983, 26: 1237-1244. 10.1002/art.1780261011.CrossRef Stuart JM, Tomoda K, Yoo TJ, Townes AS, Kang AH: Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum. 1983, 26: 1237-1244. 10.1002/art.1780261011.CrossRef
21.
go back to reference Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, Mattsson R, Holmdahl R: Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol. 1994, 24: 1698-1702. 10.1002/eji.1830240736.CrossRef Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, Mattsson R, Holmdahl R: Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol. 1994, 24: 1698-1702. 10.1002/eji.1830240736.CrossRef
22.
go back to reference Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP: Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J. 1998, 331: 727-732.CrossRef Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP: Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J. 1998, 331: 727-732.CrossRef
23.
go back to reference Malmstrom V, Michaelsson E, Burkhardt H, Mattsson R, Vuorio E, Holmdahl R: Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci USA. 1996, 93: 4480-4485. 10.1073/pnas.93.9.4480.CrossRef Malmstrom V, Michaelsson E, Burkhardt H, Mattsson R, Vuorio E, Holmdahl R: Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci USA. 1996, 93: 4480-4485. 10.1073/pnas.93.9.4480.CrossRef
24.
go back to reference Pierre P, Mellman I: Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 1998, 93: 1135-1145. 10.1016/S0092-8674(00)81458-0.CrossRef Pierre P, Mellman I: Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 1998, 93: 1135-1145. 10.1016/S0092-8674(00)81458-0.CrossRef
25.
go back to reference Michaelsson E, Holmdahl M, Engstrom A, Burkhardt H, Scheynius A, Holmdahl R: Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol. 1995, 25: 2234-2241. 10.1002/eji.1830250818.CrossRef Michaelsson E, Holmdahl M, Engstrom A, Burkhardt H, Scheynius A, Holmdahl R: Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol. 1995, 25: 2234-2241. 10.1002/eji.1830250818.CrossRef
26.
go back to reference Holmdahl M, Grubb A, Holmdahl R: Cysteine proteases in Langerhans cells limits presentation of cartilage derived type II collagen for autoreactive T cells. Int Immunol. 2004, 16: 717-726. 10.1093/intimm/dxh079.CrossRef Holmdahl M, Grubb A, Holmdahl R: Cysteine proteases in Langerhans cells limits presentation of cartilage derived type II collagen for autoreactive T cells. Int Immunol. 2004, 16: 717-726. 10.1093/intimm/dxh079.CrossRef
27.
go back to reference Huh CG, Hakansson K, Nathanson CM, Thorgeirsson UP, Jonsson N, Grubb A, Abrahamson M, Karlsson S: Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol. 1999, 52: 332-340. 10.1136/mp.52.6.332.CrossRef Huh CG, Hakansson K, Nathanson CM, Thorgeirsson UP, Jonsson N, Grubb A, Abrahamson M, Karlsson S: Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol. 1999, 52: 332-340. 10.1136/mp.52.6.332.CrossRef
28.
go back to reference Andersson M, Holmdahl R: Analysis of type II collagen reactive T cells in the mouse. I. Different regulation of autoreactive versus non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol. 1990, 20: 1061-1066. 10.1002/eji.1830200517.CrossRef Andersson M, Holmdahl R: Analysis of type II collagen reactive T cells in the mouse. I. Different regulation of autoreactive versus non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol. 1990, 20: 1061-1066. 10.1002/eji.1830200517.CrossRef
29.
go back to reference Holmdahl R: Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr Opin Immunol. 1998, 10: 710-717. 10.1016/S0952-7915(98)80093-9.CrossRef Holmdahl R: Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr Opin Immunol. 1998, 10: 710-717. 10.1016/S0952-7915(98)80093-9.CrossRef
30.
go back to reference Nandakumar KS, Svensson L, Holmdahl R: Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol. 2003, 163: 1827-1837. 10.1016/S0002-9440(10)63542-0.CrossRef Nandakumar KS, Svensson L, Holmdahl R: Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol. 2003, 163: 1827-1837. 10.1016/S0002-9440(10)63542-0.CrossRef
31.
go back to reference Michaëlsson E, Andersson M, Engström A, Holmdahl R: Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol. 1992, 22: 1819-1825. 10.1002/eji.1830220722.CrossRef Michaëlsson E, Andersson M, Engström A, Holmdahl R: Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol. 1992, 22: 1819-1825. 10.1002/eji.1830220722.CrossRef
32.
go back to reference Scheynius A, Klareskog L, Forsum U, Matsson P, Karlsson L, Peterson PA, Sundstrom C: Enrichment of epidermal Langerhans cells: studies with a monolayer technique and flow cytometry sorting. J Invest Dermatol. 1982, 78: 452-455. 10.1111/1523-1747.ep12510125.CrossRef Scheynius A, Klareskog L, Forsum U, Matsson P, Karlsson L, Peterson PA, Sundstrom C: Enrichment of epidermal Langerhans cells: studies with a monolayer technique and flow cytometry sorting. J Invest Dermatol. 1982, 78: 452-455. 10.1111/1523-1747.ep12510125.CrossRef
33.
go back to reference Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992, 176: 1693-1702. 10.1084/jem.176.6.1693.CrossRef Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992, 176: 1693-1702. 10.1084/jem.176.6.1693.CrossRef
34.
go back to reference Nandakumar KS, Holmdahl R: Arthritis induced with cartilage-specific antibodiesis IL-4-dependent. Eur J Immunol. 2006, 36: 1608-1618. 10.1002/eji.200535633.CrossRef Nandakumar KS, Holmdahl R: Arthritis induced with cartilage-specific antibodiesis IL-4-dependent. Eur J Immunol. 2006, 36: 1608-1618. 10.1002/eji.200535633.CrossRef
Metadata
Title
Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development
Authors
Alexandra Bäcklund
Meirav Holmdahl
Ragnar Mattsson
Katarina Håkansson
Veronica Lindström
Kutty Selva Nandakumar
Anders Grubb
Rikard Holmdahl
Publication date
01-04-2011
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2011
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3298

Other articles of this Issue 2/2011

Arthritis Research & Therapy 2/2011 Go to the issue